MZ Solution Collaborates with Bundang Seoul National University Hospital to Develop Tissue Regeneration Medical Devices

MGene Solution announced on the 16th that it has signed a Memorandum of Understanding (MOU) for collaboration on the "Research and Development of Medical Devices for Meniscus Replacement Based on Xenogeneic Tissue-Derived Biomaterials" with the Regenerative Medicine Center at Bundang Seoul National University Hospital.

Through this agreement, both parties will cooperate on ▲ research and development of meniscus grafts using decellularized xenogeneic tissues ▲ clinical and non-clinical testing and clinical evaluation consulting for the commercialization of meniscus replacement graft medical devices ▲ technical consulting and business exchanges to promote and strengthen the use of technologies held by both institutions ▲ joint use and support of facilities, equipment, and personnel related to regenerative medical devices using naturally derived biomaterials ▲ and mutual cooperation in discovering projects and conducting joint research on common interests.

The Regenerative Medicine Center at Bundang Seoul National University Hospital was established in April 2020 to lead research in regenerative medicine in preparation for the enforcement of the "Advanced Regenerative Medicine and Advanced Biopharmaceutical Safety and Support Act." It is one of the 22 advanced regenerative medicine implementation institutions designated by the Ministry of Health and Welfare in 2021. Currently, it is building infrastructure for conducting advanced regenerative medical clinical research and operating preclinical projects for the development of advanced biopharmaceuticals.

MGene Solution is conducting a national project related to the development of decellularized xenogeneic meniscus grafts. Recently, it ranked first among companies applying for the material component technology development xenotechnology convergence project. According to the company, although there is currently no fundamental treatment for damaged meniscus, the number of patients with meniscus injuries is rapidly increasing due to the continuous growth of sports participants and the elderly population.

A company representative stated, "Through this agreement, we will actively utilize the hospital’s infrastructure and research capabilities to accelerate research and development and commercialization of regenerative medical devices using xenogeneic tissue-derived biomaterials," adding, "We will take a step closer to our ultimate goal in the regenerative medicine business field of improving patients’ quality of life and promoting public health."

This content was produced with the assistance of AI translation services.